Wu K - Search Results

1

The role of CD44 in epithelial-mesenchymal transition and cancer development.

Xu H, Tian Y, Yuan X, Wu H, Liu Q, Pestell RG, Wu K. Xu H, et al. Among authors: wu h, wu k. Onco Targets Ther. 2015 Dec 16;8:3783-92. doi: 10.2147/OTT.S95470. eCollection 2015. Onco Targets Ther. 2015. PMID: 26719706 Free PMC article. Review.

2

Flavopiridol and trastuzumab synergistically inhibit proliferation of breast cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathways.

Wu K, Wang C, D'Amico M, Lee RJ, Albanese C, Pestell RG, Mani S. Wu K, et al. Mol Cancer Ther. 2002 Jul;1(9):695-706. Mol Cancer Ther. 2002. PMID: 12479366

3

Cyclin D1 governs adhesion and motility of macrophages.

Neumeister P, Pixley FJ, Xiong Y, Xie H, Wu K, Ashton A, Cammer M, Chan A, Symons M, Stanley ER, Pestell RG. Neumeister P, et al. Among authors: wu k. Mol Biol Cell. 2003 May;14(5):2005-15. doi: 10.1091/mbc.02-07-0102. Epub 2003 Feb 21. Mol Biol Cell. 2003. PMID: 12802071 Free PMC article.

4

The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.

D'Amico M, Wu K, Di Vizio D, Reutens AT, Stahl M, Fu M, Albanese C, Russell RG, Muller WJ, White M, Negassa A, Lee HW, DePinho RA, Pestell RG. D'Amico M, et al. Among authors: wu k. Cancer Res. 2003 Jun 15;63(12):3395-402. Cancer Res. 2003. PMID: 12810676

5

Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation.

Wang C, Pattabiraman N, Zhou JN, Fu M, Sakamaki T, Albanese C, Li Z, Wu K, Hulit J, Neumeister P, Novikoff PM, Brownlee M, Scherer PE, Jones JG, Whitney KD, Donehower LA, Harris EL, Rohan T, Johns DC, Pestell RG. Wang C, et al. Among authors: wu k. Mol Cell Biol. 2003 Sep;23(17):6159-73. doi: 10.1128/MCB.23.17.6159-6173.2003. Mol Cell Biol. 2003. PMID: 12917338 Free PMC article.

6

DACH1 inhibits transforming growth factor-beta signaling through binding Smad4.

Wu K, Yang Y, Wang C, Davoli MA, D'Amico M, Li A, Cveklova K, Kozmik Z, Lisanti MP, Russell RG, Cvekl A, Pestell RG. Wu K, et al. J Biol Chem. 2003 Dec 19;278(51):51673-84. doi: 10.1074/jbc.M310021200. Epub 2003 Oct 2. J Biol Chem. 2003. PMID: 14525983 Free article.

7

The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity.

Fu M, Rao M, Wu K, Wang C, Zhang X, Hessien M, Yeung YG, Gioeli D, Weber MJ, Pestell RG. Fu M, et al. Among authors: wu k. J Biol Chem. 2004 Jul 9;279(28):29436-49. doi: 10.1074/jbc.M313466200. Epub 2004 Apr 30. J Biol Chem. 2004. PMID: 15123687 Free article.

8

The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.

D'Amico M, Wu K, Fu M, Rao M, Albanese C, Russell RG, Lian H, Bregman D, White MA, Pestell RG. D'Amico M, et al. Among authors: wu k. Cancer Res. 2004 Jun 15;64(12):4122-30. doi: 10.1158/0008-5472.CAN-03-2519. Cancer Res. 2004. PMID: 15205322

9

Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment.

Fu M, Rao M, Bouras T, Wang C, Wu K, Zhang X, Li Z, Yao TP, Pestell RG. Fu M, et al. Among authors: wu k. J Biol Chem. 2005 Apr 29;280(17):16934-41. doi: 10.1074/jbc.M500403200. Epub 2005 Feb 14. J Biol Chem. 2005. PMID: 15713663 Free article.

10

A study of cytotoxic synergy of UCN-01 and flavopiridol in syngeneic pair of cell lines.

Wu K, D'Amico M, Wang C, Albanese C, Pestell RG, Mani S. Wu K, et al. Invest New Drugs. 2005 Aug;23(4):299-309. doi: 10.1007/s10637-005-1438-y. Invest New Drugs. 2005. PMID: 16012789

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13,717 results

Search Page